Major depressive disorder as a moderator of the relationship between heavy-episodic drinking and anxiety symptoms

被引:0
|
作者
Wojciechowski, Thomas W. W. [1 ]
机构
[1] Michigan State Univ, Sch Criminal Justice, E Lansing, MI 48824 USA
关键词
Major depressive disorder; anxiety; heavy-episodic drinking; life-course; ALCOHOL-USE DISORDERS; COMORBID ANXIETY; SENSITIVITY; PREVALENCE; COLLEGE; CIGARETTE; MOTIVES; SEEKING; SUPPORT; GENDER;
D O I
10.1080/09638237.2023.2245889
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
BackgroundMajor depressive disorder and heavy-episodic drinking are risk factors for the development of anxiety. However, the interactive effect between these constructs for predicting anxiety symptoms remains understudied.AimsThis study sought to examine how major depressive disorder moderates the relationship between heavy-episodic drinking frequency and the development of anxiety symptoms in adolescence and emerging adulthood among a sample of justice-involved youth, with expectations that the salience of this relationship may differ based on life-course stage.MethodsSeveral waves of the Pathways to Desistance study were analyzed. Poisson regression with robust standard errors was used to test the direct and interactive effects of major depressive disorder and heavy-episodic drinking frequency on anxiety symptoms at follow-up in adolescence and emerging adulthood separately.ResultsResults indicated that there was a significant negative interaction between major depressive disorder and heavy-episodic drinking frequency for predicting anxiety scores in both adolescence and emerging adulthood, though the results for adolescence were more robust.ConclusionsThese results suggest youth without major depressive disorder that engage in heavy-episodic drinking may be a priority population for treating anxiety issues, but that ceiling effects may limit the impact of the behavior on anxiety on youth with major depressive disorder.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 50 条
  • [42] Anxiety symptoms in working patients with major depressive disorder treated with vortioxetine: associations with clinical and treatment outcomes in the AtWoRC study
    Chokka, Pratap
    Ge, Holly
    Bougie, Joanna
    Ettrup, Anders
    Clerzius, Guerline
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [43] Anxiety Symptoms in Patients with Major Depressive Disorder: Commentary on Prevalence and Clinical Implications
    Malcolm Hopwood
    Neurology and Therapy, 2023, 12 : 5 - 12
  • [44] Influence of comorbid anxiety symptoms on cognitive deficits in patients with major depressive disorder
    Liu Jin
    Dong Qiangli
    Lu Xiaowen
    Sun Jinrong
    Zhang Liang
    Wang Mi
    Liu Bangshan
    Ju Yumeng
    Wan Ping
    Guo Hua
    Zhao Futao
    Zhang Xiangyang
    Zhang Yan
    Li Lingjiang
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 260 : 91 - 96
  • [45] Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
    Davis, Lori L.
    Ota, Ai
    Perry, Pamela
    Tsuneyoshi, Kana
    Weiller, Emmanuelle
    Baker, Ross A.
    BRAIN AND BEHAVIOR, 2016, 6 (10):
  • [46] Risk Factors for Anxiety in Major Depressive Disorder Patients
    Xin, Li-Min
    Chen, Lin
    Ji, Zhen-Peng
    Zhang, Suo-Yuan
    Wang, Jun
    Liu, Yan-Hong
    Chen, Da-Fang
    Yang, Fu-De
    Wang, Gang
    Fang, Yi-Ru
    Lu, Zheng
    Yang, Hai-Chen
    Hu, Jian
    Chen, Zhi-Yu
    Huang, Yi
    Sun, Jing
    Wang, Xiao-Ping
    Li, Hui-Chun
    Zhang, Jin-Bei
    Si, Tian-Mei
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2015, 13 (03) : 263 - 268
  • [47] The Relationship between Anxiety, Subjective and Objective Sleep, Chronotype and Circadian Rhythms with Depressive Symptoms in Insomnia Disorder
    Comas, Maria
    Solis Flores, Alejandra
    Lovato, Nicole
    Miller, Christopher B.
    Bartlett, Delwyn J.
    Grunstein, Ronald R.
    Chapman, Julia
    Gordon, Christopher J.
    BRAIN SCIENCES, 2023, 13 (04)
  • [48] Effectiveness of 8-week TReatment with vortioxetine on depressive symptoms in major depressive disorder patients with comorbid generalized anxiety disorder in UAE (TRUE)
    Badr, Bassem
    Gailani, Hana Al
    Alkhoori, Samia
    Butt, Hania
    Daher, Michel
    Dheyaa, Bassam
    Hindy, Nasser El
    Eid, Mohamed Wafeek
    Elsaadouni, Nisrin
    Faia, Valentina
    Haweel, Alaa
    Khammas, Tarek
    Omar, Hussein
    Tadros, George
    Yacoub, Charles
    Talaat, Tamer
    El-Shafei, Ahmed
    ANNALS OF GENERAL PSYCHIATRY, 2024, 23 (01)
  • [49] Hypomanic symptoms in major depressive disorder: Prognostic impact and treatment issues
    Olgiati, Paolo
    Kasper, Siegfried
    Zohar, Joseph
    Souery, Daniel
    Montgomery, Stuart
    Ferentinos, Panagiotis
    Rujescu, Dan
    Zanardi, Raffaella
    Fugger, Gernot
    Ferri, Raffaele
    Tripodi, Mariangela
    Baune, Bernhard T.
    Fabbri, Chiara
    Mendlewicz, Julien
    Serretti, Alessandro
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 369 : 1021 - 1030
  • [50] The Underlying Role of Negative Affect in the Association between PTSD, Major Depressive Disorder, and Generalized Anxiety Disorder
    Byllesby, Brianna M.
    Charak, Ruby
    Durham, Tory A.
    Wang, Xin
    Elhai, Jon D.
    JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT, 2016, 38 (04) : 655 - 665